Affinity Labelling of Cephalosporin C Acylase from Pseudomonas sp. : N176 with a Substrate Analogue, 7β-(6-Bromohex-anoylamido)cephalosporanic Acid
スポンサーリンク
概要
- 論文の詳細を見る
We synthesized 7β-(6-bromohexanoylamido)cephalosporanic acid (6-BH-7ACA), a substrate analogue of an acylase from Pseudomonas N176 (N176 acylase) to determine the substrate binding site of the acylase. The enzyme was inactivated by incubation with 6-BH-7ACA in a time-dependent manner. A double reciprocal plot of the pseudo-first-order rate constant (k_<obs>) against the 6-BH-7ACA concentration gave a strainght line (k_<max>=0.113 min^<-1>, K_1=0.51 mM). A plot of log k_<obs> against log [6-BH-7ACA] was linear with a slope of 0.87. Inactivation of the enzyme with 6-BH-7ACA was inhibited by addition of 7-aminocephalosporanic acid and glutaric acid. These data indicate that 6-BH-7ACA functions as an affinity label reagent and the inactivation by 6BH-7ACA is due to the modification of a single residue located in the neighborhood of the substrate binding region of the acylase. The digest of the inactivated enzyme with lysylendopeptidase was fractionated by reversed phase high-performance liquid chromatography (HPLC). One fragment was eluted with a different retention time from the corresponding fragment of the intact enzyme. From additional α-chymotrptic digestion followed by amino acid sequence analysis, Tyr^<270> was determined as the site labelled by 6-BH-7ACA. Replacing Try^<270> with a Phe residue by site-directed mutagenesis caused a decrease in the enzyme capability (k_<cat>/K_m). While the K_m of the mutant acylase increased slightly, the k_<cat> decreased to about 50% of that of the wild-type. These results indicate that although labelled Tyr^<270> is not essential, it does play an important role in the enzymatic activity.
- 社団法人日本生物工学会の論文
- 1994-06-25
著者
-
ISHII YOSHINORI
Pharmacological Research Laboratories, Fujisawa Pharmaceutical Co. Ltd.
-
SAITO YOSHIMASA
Pharmacological Research Laboratories, Fujisawa Pharmaceutical Co. Ltd.
-
Ishii Y
Pharmacological Research Laboratories And Exploratory Research Laboratories
-
Ishii Yoshinori
Pharmacological Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Ishii Y
Fermentation Development Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Niwa Mineo
Pharmacological Research Laboratories And Exploratory Research Laboratories
-
Niwa Mineo
Institute For Medicinal Resources The University Of Tokushima
-
SASAKI HITOSHI
Pharmacological Research Laboratories, Fujisawa Pharmaceutical Co. Ltd.,
-
UCHIYAMA FUMIAKI
Pharmacological Research Laboratories, Fujisawa Pharmaceutical Co. Ltd.,
-
HAYASHI MASAKO
Pharmacological Research Laboratories, Fujisawa Pharmaceutical Co. Ltd.,
-
NAKAMURA SACHIKO
Pharmacological Research Laboratories, Fujisawa Pharmaceutical Co. Ltd.,
-
Ishii Y
Ishii Orthopaedic And Rehabilitation Clinic
-
Niwa M
Institute For Medicinal Resources The University Of Tokushima
-
Sasaki H
Takushoku Univ. Hachioji‐shi Jpn
-
Hayashi M
Nec Corp. Tsukuba‐shi Jpn
-
Uchiyama Fumiaki
Pharmacological Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Nakamura S
Kurimoto Ltd. Osaka Jpn
-
Hayashi Masako
Pharmacological Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
関連論文
- An Approach to High-Level Production of Cephalosporin Acylase from Pseudomonas strain N176 in Escherichia coli
- Purification and Molecular Characterization of a Quinoprotein Alcohol Dehydrogenase from Pseudogluconobacter saccharoketogenes IFO 14464
- Comparative Characterization of New Glutaryl 7-ACA and Cephalosporin C Acylases
- Cloning and Nucleotide Sequencing of New Glutaryl 7-ACA and Cephalosporin C Acylase Genes from Pseudomonas Strains
- Direct Identification of a Novel Disulfide Bond Linkage System of New Isolated Isomer (Isomer V) in Recombinantly Produced h-IGF-I
- Synthesis of Two Possible Disulfide Bonds Containing Peptide Fragments(Cys^6-Cys^, Cys^-Cys^(Type I), and Cys^6-Cys^, Cys^-Cys^(Type II) of h-IGF-I) for the Identification of Disulfide Bond Linkage in Recombinantly Produced h-IGF-I
- Chemical Modification and Site-Directed Mutagenesis of Tyrosine Residues in Cephalosporin C Acylase from Pseudomonas Strain N176
- Affinity Labelling of Cephalosporin C Acylase from Pseudomonas sp. : N176 with a Substrate Analogue, 7β-(6-Bromohex-anoylamido)cephalosporanic Acid
- A Novel 7-β-(4-Carboxybutanamido)-Cephalosporanic Acid Acylase Isolated from Pseudomonas Strain C427 and Its High-Level Production in Escherichia coli
- Effect of flexion angle on coronal laxity in patients with mobile-bearing total knee arthroplasty prostheses
- Coronal laxity in extension in vivo after total knee arthroplasty
- Modulation of Alamethicin Assembly by Hybridization
- Preparation of Peptide Thioester Segments Using Fmoc-Solid-Phase Peptide Synthesis
- Large Scale Purification of Recombinant Insulin-Like Growth Factor I (IGF-I, Mecasermin) from a Fused Protein Produced in Escherichia coli
- An Approach to High-Level Production of Mecasermin (Somatomedin C) Fused Protein in Escherichia coli HB101